Skip to main content
. 2022 Dec 2;14(12):2696. doi: 10.3390/pharmaceutics14122696

Table 2.

Antidepressant non-adherence prevalence (%) among the Castile and Leon (Spain) population.

Non-Adherence Prevalence % (95% CI) p
Sociodemographic Characteristics
Sex
Male 20.56 (20.39–20.74) 0.001
Female 19.59 (19.42–19.76)
Urbanicity
Yes 20.92 (20.75–21.1) 0.001
No 17.96 (17.79–18.12)
Institutionalized
Yes 13.61 (13.47–13.76) 0.001
No 20.39 (20.22–20.57)
Health related characteristics
Multiple prescribers
Yes (≥3 prescribers) 19.19 (19.02–19.36) 0.001
No (<3 prescribers) 20.8 (20.63–20.97)
Polypharmacy
Yes (≥5 drugs) 18.43 (18.27–18.6) 0.001
No (<5 drugs) 24.85 (24.66–25.03)
Antidepressant class
TCAs 23.99 (23.8–24.17) 0.001
SSRIs 20.19 (20.01–20.36)
Other antidepressants 18.5 (18.34–18.67)
Mental health diagnostics
Pain (different etiologies) 24.81 (24.62–24.99) 0.001
Anxiety 21.55 (21.37–21.72)
Depression and Anxiety 19.47 (19.3–19.64)
Depression 17.83 (17.67–17.99)
Other psychiatric diagnosis 17.75 (17.59–17.92)

Abbreviations: 95% CI: confidence interval, SSRIs, Selective Serotonin Reuptake Inhibitors, TCAs: Tricyclic Antidepressants.